Aczone Approval History
- FDA approved: Yes (First approved July 7th, 2005)
- Brand name: Aczone
- Generic name: dapsone
- Company: Atrix Laboratories, Inc. and Fujisawa Healthcare, Inc.
- Treatment for: Acne
Aczone (dapsone) is a sulfone in an aqueous gel base for topical dermatologic use. Aczone is indicated for the topical treatment of acne vulgaris.
Development History and FDA Approval Process for Aczone
|May 29, 2007||QLT USA, Inc. files Aczone labeling supplement for removal of blood screening requirement|
|Sep 1, 2004||Atrix and Fujisawa Submit New Drug Application for Acne Product|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.